ACC patients with high expression of SLC7A11 exhibit increased sensitivity to certain anti-tumor drugs (YK-4-279, tozasertib, docetaxel, vinblastine and so on), suggesting an important role for SLC7A11 in the treatment of ACC patients. The gene discussed is SLC7A11; the disease is neoplasm.